Kwality Pharmaceuticals Limited (BOM:539997)

Kwality Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 11, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	14,132	9,017	4,248	3,191	6,018	581
Market Cap Growth	57.13%	112.27%	33.12%	-46.97%	935.71%	119.18%
Enterprise Value	14,880	9,948	5,076	4,145	6,180	772
Last Close Price	1362.00	869.05	409.40	307.55	580.00	56.00
PE Ratio	24.97	22.63	17.85	16.47	5.02	3.84
PS Ratio	3.06	2.44	1.38	1.27	1.32	0.22
PB Ratio	4.90	3.44	1.91	1.60	3.35	0.97
P/TBV Ratio	4.90	3.44	1.90	1.59	3.32	0.95
P/FCF Ratio	-	30.65	32.33	-	110.54	17.58
P/OCF Ratio	-	17.11	9.88	7.71	9.93	2.18
EV/Sales Ratio	3.22	2.69	1.65	1.65	1.36	0.29
EV/EBITDA Ratio	14.12	12.13	7.46	6.73	3.56	2.56
EV/EBIT Ratio	16.90	15.61	10.48	8.88	3.80	3.26
EV/FCF Ratio	-	33.81	38.62	-	113.51	23.35
Debt / Equity Ratio	0.38	0.43	0.44	0.45	0.35	0.69
Debt / EBITDA Ratio	1.16	1.37	1.44	1.46	0.36	1.37
Debt / FCF Ratio	2.99	3.82	7.47	-	11.61	12.47
Asset Turnover	0.97	0.88	0.82	0.72	1.80	1.76
Inventory Turnover	2.61	2.33	1.92	1.63	4.88	5.75
Quick Ratio	1.23	1.07	0.90	0.68	0.65	0.59
Current Ratio	1.88	1.67	1.60	1.65	1.63	1.35
Return on Equity (ROE)	18.58%	16.41%	11.20%	10.18%	100.10%	28.41%
Return on Assets (ROA)	10.90%	9.47%	8.10%	8.40%	40.13%	9.90%
Return on Invested Capital (ROIC)	15.59%	13.89%	12.33%	13.75%	75.28%	19.99%
Return on Capital Employed (ROCE)	24.70%	23.00%	20.00%	20.50%	80.90%	26.90%
Earnings Yield	4.00%	4.42%	5.60%	6.07%	19.94%	26.07%
FCF Yield	-	3.26%	3.09%	-1.97%	0.91%	5.69%
Buyback Yield / Dilution	-0.01%	-	-	-	-0.00%	-
Total Shareholder Return	-0.01%	-	-	-	-0.00%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.